Page last updated: 2024-10-30

maprotiline and Ventricular Fibrillation

maprotiline has been researched along with Ventricular Fibrillation in 1 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manoach, M1
Erez, M1
Wozner, D1
Varon, D1

Other Studies

1 other study available for maprotiline and Ventricular Fibrillation

ArticleYear
Ventricular defibrillating properties of catecholamine uptake inhibitors.
    Life sciences, 1992, Volume: 51, Issue:17

    Topics: Amphetamine; Animals; Antidepressive Agents, Tricyclic; Cats; Cocaine; Desipramine; Electrocardiogra

1992